EU Clears AbbVie Takeover of Allergan Subject to Conditions EU Clears AbbVie Takeover of Allergan Subject to Conditions
The European Commission said on Friday it had approved U.S. drugmaker AbbVie ' s planned $63 billion acquisition of Botox-maker Allergan, subject to conditions.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 13, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
GP slams 'Wild West' approach to Botox - after Love Island star 'qualifies' to give treatments
Rykard Jenkins has been sharing his experience of training to become an aesthetic practitioner. However, one aesthetic doctor has criticised companies offering such training to non medics. (Source: the Mail online | Health)
Source: the Mail online | Health - November 22, 2019 Category: Consumer Health News Source Type: news
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
IT'S BO-TIME: BRAND CELEBRATES HOLIDAY WITH EXCLUSIVE ONE-DAY-ONLY OFFER
DUBLIN, Nov. 18, 2019 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN), the maker of BOTOX® Cosmetic, has announced the first-ever National BOTOX® Cos... Biopharmaceuticals, Dermatology Allergan, BOTOX, onabotulinumtoxinA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2019 Category: Pharmaceuticals Source Type: news
Why women in their 40s are seeking full-on facelifts instead of botox
Civil servant Mel Beard, 49, from West Sussex, pictured left before her facelift and right after the procedure said she considered going under the knife five years earlier. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2019 Category: Consumer Health News Source Type: news
Allergan's Botox gets pediatric approval
Allergan announced that the U.S. FDA has approved the company ' s supplemental BLA for Botox for the treatment of pediatric patients (2 to 17 years of age) with lower limb spasticity, excluding spasticity caused by cerebral palsy. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 25, 2019 Category: Pharmaceuticals Source Type: news
FDA Approves Botox (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
DUBLIN, Oct. 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) approved the company ' s supplemental Biologics License Application (sBLA) for Botox for the treatment of pediatric... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 24, 2019 Category: Drugs & Pharmacology Source Type: news
FDA Approves Botox for Lower-Limb Spasticity in Children FDA Approves Botox for Lower-Limb Spasticity in Children
The FDA has approved Botox to ease lower-limb spasticity in children and adolescents aged 2 to 17 years, excluding spasticity caused by cerebral palsy.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 24, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy
Approval Marks 11th BOTOX® Therapeutic Indication and Comes 30 Years After the First Indications Were Approved
DUBLIN, Oct. 24, 2019 -- (Healthcare Sales & Marketing Network) -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug A... Biopharmaceuticals, FDA Allergan, BOTOX, onabotulinumtoxinA, limb spasticity (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 24, 2019 Category: Pharmaceuticals Source Type: news
Fort Washington Man Sentenced to 66 Months in Federal Prison for Two Separate Drug Cases
Daniel Mark Wilkerson, Ft. Washington MD, prescription drugs, federal military hospitals, Rodger Gurdon, Issa Wasco Koroma, Norditropon, Humatrope, Somatotropin, Botox, human growth hormone, pharmacies, Ft. Belvoir Community Hospital VA, Walter Reed National Military Medical Center, Bethesda MD, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 7, 2019 Category: Medical Law Authors: DOJ Source Type: news
Botox bars raise concern among medical experts and patients
Nearly 16 million minimally invasive cosmetic procedures took place last year in the U.S. That includes nearly 7.5 million botox, and other neurotoxin injections to reduce wrinkles as well as 2.5 million filler injections to shape the face. These enhancements traditionally require a visit to a doctor's office but as Dr. Tara Narula shows us, new salons are offering injections in a more casual setting -- creating potential risks. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 2, 2019 Category: Consumer Health News Source Type: news
Botox bars raise concern among medical experts: "Things can happen"
New salons are offering the procedure in a more casual setting – but experts say there's risks (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 2, 2019 Category: Consumer Health News Source Type: news
Patients who bought a doctor’s Botox services on Groupon got phony injections, officials say
Authorities raided her Coral Springs, Fla., office earlier this week as part of a year-long investigation into her practices, local news reports say. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 14, 2019 Category: Consumer Health News Authors: Hannah Knowles Source Type: news
Evolus Says Launch of Its Botox Rival Ahead of Its Expectations Evolus Says Launch of Its Botox Rival Ahead of Its Expectations
Evolus Inc on Monday reported revenue of $2.3 million from early sales of its newly launched rival to Allergan Plc ' s Botox, ahead of its own expectations.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 13, 2019 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine News Source Type: news
JPMorgan set to scoop record fee for Allergan sale
AbbVie’s planned $63bn purchase of the Botox-maker will earn $123m for bank (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 13, 2019 Category: Pharmaceuticals Source Type: news
Botox less costly but more AEs than neuromodulation
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 31, 2019 Category: Drugs & Pharmacology Source Type: news
